Ryan Mason, Jeffrey D. Erb to join as chief marketing officer and chief media officer, respectively.
Fishawack Health, a commercialization partner for the biopharmaceutical, medical technology, and wellness industries, has announced the addition of Ryan Mason as chief marketing and creative officer, bringing together creative, brand and engagement strategy and media and analytics teams.
As a part of this integration, the organization has also revealed the hiring of Jeffrey D. Erb as chief media officer. As part of his job, Erb will be responsible for growing the company's media and analytics capabilities to expand specialized tools and resources in house.
"Ryan's ability to foster and build teams across creative, brand and engagement strategy and media and analytics disciplines makes him the perfect leader as we continue to offer stakeholder-centric and integrated solutions, seamlessly connecting strategy with execution," said Mario Muredda, president, marketing, Fishawack Health. "Jeff's deep expertise in advancing media and analytics capabilities is core to helping our clients deliver personalized experiences that increase awareness, shift beliefs and behaviors, and are optimized in real time."
Reference: Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer. PR Newswire. May 31, 2023. Accessed June 5, 2023. https://www.prnewswire.com/news-releases/fishawack-health-deepens-key-capabilities-and-builds-an-integrated-delivery-model-under-new-chief-marketing-and-creative-officer-301837892.html
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.